These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37496455)

  • 41. Benchmark Dose Modeling Estimates of the Concentrations of Inorganic Arsenic That Induce Changes to the Neonatal Transcriptome, Proteome, and Epigenome in a Pregnancy Cohort.
    Rager JE; Auerbach SS; Chappell GA; Martin E; Thompson CM; Fry RC
    Chem Res Toxicol; 2017 Oct; 30(10):1911-1920. PubMed ID: 28927277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.
    Sand S; von Rosen D; Victorin K; Filipsson AF
    Toxicol Sci; 2006 Mar; 90(1):241-51. PubMed ID: 16322076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay.
    Wills JW; Johnson GE; Battaion HL; Slob W; White PA
    Environ Mol Mutagen; 2017 Dec; 58(9):632-643. PubMed ID: 28945287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benchmark dose analysis framework for developing wildlife toxicity reference values.
    Mayfield DB; Skall DG
    Environ Toxicol Chem; 2018 May; 37(5):1496-1508. PubMed ID: 29315767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benchmark dose analysis of developmental toxicity in rats exposed to boric acid.
    Allen BC; Strong PL; Price CJ; Hubbard SA; Daston GP
    Fundam Appl Toxicol; 1996 Aug; 32(2):194-204. PubMed ID: 8921322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Derivation of a biological limit value (BLV) for inorganic lead based on lead-induced genotoxicity in workers using the benchmark dose approach (BMD).
    Duydu Y
    J Trace Elem Med Biol; 2022 Jan; 69():126894. PubMed ID: 34749035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology-based risk assessment using the benchmark dose/margin of exposure approach: the example of ethanol and liver cirrhosis.
    Lachenmeier DW; Kanteres F; Rehm J
    Int J Epidemiol; 2011 Feb; 40(1):210-8. PubMed ID: 20819784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A benchmark dose analysis of prenatal exposure to polychlorinated biphenyls.
    Jacobson JL; Janisse J; Banerjee M; Jester J; Jacobson SW; Ager JW
    Environ Health Perspect; 2002 Apr; 110(4):393-8. PubMed ID: 11940457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative Interpretation of Genetic Toxicity Dose-Response Data for Risk Assessment and Regulatory Decision-Making: Current Status and Emerging Priorities.
    White PA; Long AS; Johnson GE
    Environ Mol Mutagen; 2020 Jan; 61(1):66-83. PubMed ID: 31794061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of benchmark dose uncertainty measurements for robust comparative potency analyses.
    Wheeldon RP; Dertinger SD; Bryce SM; Bemis JC; Johnson GE
    Environ Mol Mutagen; 2021 Mar; 62(3):203-215. PubMed ID: 33428310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolomics Simultaneously Derives Benchmark Dose Estimates and Discovers Metabolic Biotransformations in a Rat Bioassay.
    Sostare E; Bowen TJ; Lawson TN; Freier A; Li X; Lloyd GR; Najdekr L; Jankevics A; Smith T; Varshavi D; Ludwig C; Colbourne JK; Weber RJM; Crizer DM; Auerbach SS; Bucher JR; Viant MR
    Chem Res Toxicol; 2024 Jun; 37(6):923-934. PubMed ID: 38842447
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Jensen SM; Kluxen FM; Streibig JC; Cedergreen N; Ritz C
    PeerJ; 2020; 8():e10557. PubMed ID: 33362981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a benchmark dose for lead-exposure based on its induction of micronuclei, telomere length changes and hematological toxicity.
    Wang T; Tu Y; Zhang G; Gong S; Wang K; Zhang Y; Meng Y; Wang T; Li A; Christiani DC; Au W; Zhu Y; Xia ZL
    Environ Int; 2020 Dec; 145():106129. PubMed ID: 32950787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Model averaging methods for the evaluation of dose-response model uncertainty when assessing the suitability of studies for estimating risk.
    Mendez W; Shao K; Lee JS; Cote I; Druwe IL; Davis A; Gift JS
    Environ Int; 2020 Oct; 143():105857. PubMed ID: 32615345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of benchmark dose models in risk assessment for occupational handlers of eight pesticides used in pome fruit production.
    Pouzou JG; Kissel J; Yost MG; Fenske RA; Cullen AC
    Regul Toxicol Pharmacol; 2020 Feb; 110():104504. PubMed ID: 31655092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The benchmark dose approach in food risk assessment: is it applicable and worthwhile?
    Muri SD; Schlatter JR; Brüschweiler BJ
    Food Chem Toxicol; 2009 Dec; 47(12):2906-25. PubMed ID: 19682530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of study-specific MOE-like estimates to prioritize health effects from chemical exposure for analysis in human health assessments.
    Hobbie K; Shao K; Henning C; Mendez W; Lee JS; Cote I; Druwe IL; Davis JA; Gift JS
    Environ Int; 2020 Nov; 144():105986. PubMed ID: 32871380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.